Intravenous immunoglobulin in the treatment of human immunodeficiency virus-related thrombocytopenia
β Scribed by Dr. Mark U. Rarick; Terri Montgomery; Amitabha Mazumder; Parkash S. Gill; Carmen Loureiro; Alexandra M. Levine; Susan Groshen; Jane Sullivan-Halley; Denise Jamin
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 533 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A 72-year-old woman with human immunodeficiency virus (HIV)-related axonal polyradiculoneuropathy of the lower extremities was treated with 3'-azido-2',3'-dideoxythymidine (AZT), 250 mg every 4 hours. Before therapy she had rapidly progressive weakness in both legs and when treatment began she could
Infection with the human immunodeficiency virus (HIV) frequently is complicated with thrombocytopenia (HIV-Thr) during all stages of the infection. The treatments for autoimmune thrombocytopenic purpura (ITP) are used in HIV-Thr; however, their effects upon the immune status of patients with acquire